FibroGen, Inc.FGENNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, modest growth trend.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-150.42M
↑ 11% above average
Average (9y)
$-168.45M
Historical baseline
Range
High:$-53.65M
Low:$-322.72M
CAGR
+7.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-150.42M | +53.4% |
| 2023 | $-322.72M | -7.2% |
| 2022 | $-301.02M | -4.3% |
| 2021 | $-288.53M | -50.4% |
| 2020 | $-191.88M | -114.8% |
| 2019 | $-89.31M | -3.0% |
| 2018 | $-86.69M | +29.3% |
| 2017 | $-122.61M | -128.5% |
| 2016 | $-53.65M | +30.9% |
| 2015 | $-77.63M | - |